Der Kaninchen Polyklonal anti-CYFIP2 Antikörper wird verwendet zum Nachweis von CYFIP2 in Proben von Human, Maus und Ratte. Er wurde validiert für WB und ELISA.
Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-2000,ELISA 1:10000-20000
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
1 mg/mL
Buffer
Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
-20 °C
Informationen zur Lagerung
Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
Haltbarkeit
12 months
Target
CYFIP2
(Cytoplasmic FMR1 Interacting Protein 2 (CYFIP2))
Andere Bezeichnung
CYFIP2
Hintergrund
Cytoplasmic FMR1-interacting protein 2, p53-inducible protein 121CYFIP2 belongs to the CYFIP family and is involved in T-cell adhesion and p53-dependent induction of apoptosis. CYFIP2 mRNA is ubiquitously expressed and particularly abundant in the central nervous system. Recently, CYFIP2 was regarded as one of the ALS potential biomarkes in non-neural tissues from amyotrophic lateral sclerosis (ALS) patients that may have direct diagnostic and therapeutic implications to the disease.